Abstract:Objectives:To construct tumor angiogenesis-targeting paramagnetic liposomes and investigate their potential value as a magnetic resonance imaging(MRI) to detect minute tumor foci in tumor-bearing nude mice.Methods:Peptide-palmitic acid conjugate was prepared using fluorenylmethoxy carbony(Fmoc) solid-phase synthetic method.Angiogenesis-targeting paramagnetic liposome particles were prepared by the thin film dispersion-sonication method.Entrapped efficiency of Gd-DPTA-BMA was determined by centrifugal ultrafiltration.The average size of liposome particles was determined by laser particle sizing analysis.Gd3+ concentration was determined by chlorophosphonazo Ⅲ colorimetry.The signal enhancement ratio of targeted paramagnetic liposome particles was evaluated by MRI in human lung adenocarcinoma implanted in nude mice.Results:Five paramagnetic liposome particles which targeted αVβ3,vascular endothelial growth factor receptor(VEGFR)-1 and-2 and had different conjugation forms were prepared.Entrapped efficiency of the five prepared paramagnetic liposome particles was from 55.5% to 60.1%,and average particle size was from 109-128 nm.Integrin αⅤβ3 and VEGFR-2-targeted paramagnetic liposome particles showed good tumor-specific MRI signal enhancement in xenograft of the nude mice,especially for Integrin αVβ3 receptor.Spacer 6-aminohexanoic acid demonstrated the better signal enhancement than the other two linkages.Tumor relative signal intensity was increased 1.8-2.8 folds than control in T1 weighted MR imaging.Minute tumor nodules(2-5 mm) were clearly identified.Biodistribution analysis showed that the Gd3+ concentration in tumor was significantly higher than that in the heart,lung,liver,and muscle,and slightly higher than that in the spleen and kidney.Conclusion:Angiogenesis-targeting paramagnetic liposome particles were tumor-specific and lasted for a long time.MRI signal enhancement was higher and minute tumor foci(2-5 mm) were clearly identified.It can be developed as a potential tumor-specific MRI contrast agent for the early diagnosis of cancer and metastases.

A nanocomplex system as targeted contrast agent delivery vehicle for magnetic resonance imaging dynamic contrast enhancement study.

Dual Integrin Αvβ 3 and NRP-1-Targeting Paramagnetic Liposome for Tumor Early Detection in Magnetic Resonance Imaging

A Targeted Nanoglobular Contrast Agent from Host-Guest Self-Assembly for MR Cancer Molecular Imaging.

Magnetic Resonance Imaging Contrast Agent: Crgd-Ferric Oxide Nanometer Particle and Its Role in the Diagnosis of Tumor

Biocompatible Nanocomplexes for Molecular Targeted MRI Contrast Agent

Targeted Contrast Agent Specific to an Oncoprotein in Tumor Microenvironment with the Potential for Detection and Risk Stratification of Prostate Cancer with MRI.

Gadolinium-based contrast agents for tumor targeting imaging

RGD-targeted Paramagnetic Liposomes for Early Detection of Tumor: in Vitro and in Vivo Studies.

Study on angiogenesis-targeting paramagnetic nanoliposomes in MRI for diagnosis of pulmonary carcinoma

A dual-targeted Gd-based contrast agent for magnetic resonance imaging in tumor diagnosis

Preparation and in Vitro Evaluation of a MRI Contrast Agent Based on Aptamer-Modified Gadolinium-Loaded Liposomes for Tumor Targeting

Geometrical Confinement Directed Albumin-Based Nanoprobes As Enhanced T-1 Contrast Agents for Tumor Imaging

Gadolinium-Loaded Solid Lipid Nanoparticles as a Tumor-Absorbable Contrast Agent for Early Diagnosis of Colorectal Tumors Using Magnetic Resonance Colonography.

A Cation Exchange Strategy to Construct a Targeting Nanoprobe for Enhanced T1-weighted MR Imaging of Tumors

In Vivo Tumor Visualization Through MRI Off‐On Switching of NaGdF4–CaCO3 Nanoconjugates

A dextran-based probe for the targeted magnetic resonance imaging of tumours expressing prostate-specific membrane antigen

A Bimodal MRI and NIR Liposome Nanoprobe for Tumor Targeted Molecular Imaging.

Protein-Based Mri Contrast Agents for Molecular Imaging of Prostate Cancer

A Dual Ligand Targeted Nanoprobe with High MRI Sensitivity for Diagnosis of Breast Cancer

Oligoethylenimine-Grafted Chitosan As Enhanced T-1 Contrast Agent for in Vivo Targeted Tumor Mri

Chlorotoxin-modified macromolecular contrast agent for MRI tumor diagnosis.